Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $14.1 Million - $16.5 Million
-142,703 Reduced 11.19%
1,132,818 $131 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $8.63 Million - $10.1 Million
89,598 Added 7.56%
1,275,521 $131 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $49.3 Million - $52.2 Million
459,839 Added 63.33%
1,185,923 $129 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $45.3 Million - $82.6 Million
726,084 New
726,084 $82.6 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Melqart Asset Management (Uk) LTD Portfolio

Follow Melqart Asset Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.